A detailed history of Armistice Capital, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Armistice Capital, LLC holds 49,762 shares of BSX stock, worth $5.2 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
49,762
Holding current value
$5.2 Million
% of portfolio
0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$89.38 - $106.18 $4.45 Million - $5.28 Million
49,762 New
49,762 $5.02 Million
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $2.45 Million - $2.82 Million
33,555 Added 144.01%
56,855 $4.76 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $1.57 Million - $1.81 Million
23,300 New
23,300 $1.79 Million
Q4 2020

Feb 16, 2021

BUY
$33.15 - $41.97 $16.6 Million - $21 Million
500,000 New
500,000 $18 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $150B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.